Beta Bionics, Inc.
BBNX
$22.26
$1.778.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -16.64% | -130.19% | 3.93% | -- | |
| Total Depreciation and Amortization | 13.37% | 7.28% | -2.76% | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -4.96% | 214.71% | -47.75% | -- | |
| Change in Net Operating Assets | 44.19% | -32.60% | -472.97% | -- | |
| Cash from Operations | -11.09% | -64.48% | -124.97% | -- | |
| Capital Expenditure | -250.89% | 17.98% | -79.23% | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 108.88% | -2,334.86% | 58.00% | -- | |
| Cash from Investing | 87.06% | -2,443.30% | 57.39% | -- | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 250.00% | 3,518,550.00% | 322.22% | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 139.25% | 3,518,550.00% | 632,033.33% | -- | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 18.41% | 367.51% | 117.05% | -- | |